{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:13:48Z","timestamp":1787004828903,"version":"build-2736575974"},"reference-count":14,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1053\/j.seminhematol.2014.03.007","type":"journal-article","created":{"date-parts":[[2014,4,2]],"date-time":"2014-04-02T01:05:30Z","timestamp":1396400730000},"page":"98-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Direct Oral Anticoagulants\u2014Interference With Laboratory Tests and Mechanism of Action"],"prefix":"10.1053","volume":"51","author":[{"given":"Dimitrios A.","family":"Tsakiris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2014.03.007_bib1","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1182\/asheducation-2013.1.464","article-title":"Pros and cons of new oral anticoagulants","volume":"2013","author":"Bauer","year":"2013","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"Suppl 1","key":"10.1053\/j.seminhematol.2014.03.007_bib2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/jth.12227","article-title":"The role of the laboratory in treatment with new oral anticoagulants","volume":"11","author":"Baglin","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2014.03.007_bib3","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.thromres.2011.06.031","article-title":"Rivaroxaban: quantification by anti-FXa assay and influence on coagulation tests: a study in 9 Swiss laboratories","volume":"129","author":"Asmis","year":"2012","journal-title":"Thromb Res"},{"key":"10.1053\/j.seminhematol.2014.03.007_bib4","first-page":"240","article-title":"Assessment of apixaban plasma levels by laboratory tests: suitability of three anti-Xa assays. A multicentre French GEHT study","volume":"111","author":"Gouin-Thibault","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2014.03.007_bib5","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1365-2125.2012.04409.x","article-title":"A randomized trial of the safety, pharmacokinetics and pharmacodynamics of edoxaban, an oral factor Xa inhibitor, following a switch from warfarin","volume":"75","author":"Mendell","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1053\/j.seminhematol.2014.03.007_bib6","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1055\/s-0033-1354423","article-title":"Clinical judgment when using coagulation tests during direct oral anticoagulant treatment: a concise review","volume":"39","author":"Di Minno","year":"2013","journal-title":"Semin Thromb Hemost"},{"key":"10.1053\/j.seminhematol.2014.03.007_bib7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1477-9560-11-22","article-title":"Main considerable factors for correct laboratory test interpretation under DOA treatment","volume":"11","author":"Mani","year":"2013","journal-title":"Thromb J"},{"key":"10.1053\/j.seminhematol.2014.03.007_bib8","doi-asserted-by":"crossref","first-page":"w13684","DOI":"10.4414\/smw.2012.13684","article-title":"Anticoagulant treatment: the end of the old agents?","volume":"142","author":"Graf","year":"2012","journal-title":"Swiss Med Wkly"},{"key":"10.1053\/j.seminhematol.2014.03.007_bib9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11239-013-0907-y","article-title":"Measuring the anticoagulant effects of target specific oral anticoagulants-reasons, methods and current limitations","volume":"36","author":"Mani","year":"2013","journal-title":"J Thromb Thrombolysis"},{"key":"10.1053\/j.seminhematol.2014.03.007_bib10","first-page":"1375","article-title":"[Questions and answers regarding the use of rivaroxaban in daily practice]","volume":"9","year":"2013","journal-title":"Rev Med Suisse"},{"key":"10.1053\/j.seminhematol.2014.03.007_bib11","first-page":"10","article-title":"Practical considerations in the use of novel oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation","author":"Deitelzweig","year":"2013","journal-title":"Cardiovasc Ther"},{"key":"10.1053\/j.seminhematol.2014.03.007_bib12","first-page":"294","article-title":"[Dabigatran therapy\u2014perioperative management and interpretation of coagulation tests]","volume":"32","author":"Spannagl","year":"2012","journal-title":"Hamostaseologie"},{"key":"10.1053\/j.seminhematol.2014.03.007_bib13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1160\/TH12-12-0898","article-title":"Impact of apixaban on routine and specific coagulation assays: a practical laboratory guide","volume":"110","author":"Douxfils","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2014.03.007_bib14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1477-9560-11-6","article-title":"Variability between laboratories performing coagulation tests with identical platforms: a nationwide evaluation study","volume":"11","author":"Nagler","year":"2013","journal-title":"Thromb J"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003719631400016X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003719631400016X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:23:24Z","timestamp":1758522204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003719631400016X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S003719631400016X"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2014.03.007","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct Oral Anticoagulants\u2014Interference With Laboratory Tests and Mechanism of Action","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2014.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}